Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | GCGR | P47871 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 2/20 | 0.30 |
| ▸ | ICMT | O60725 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5136610 | 0.94 | MEN1 (0.36) | MEN1KMT2AS1PR1MAOAMAOB | |
| SCHEMBL5136271 | 0.92 | MEN1 (0.37) | MEN1KMT2AMAOAMAOBP2RX7 | |
| SCHEMBL5136275 | 0.87 | MEN1 (0.38) | MEN1KMT2AS1PR1GCGRP2RX7 | |
| SCHEMBL5134757 | 0.82 | ICMT (0.35) | MEN1KMT2AS1PR1P2RX7ESR1 | |
| SCHEMBL5073855 | 0.81 | TSHR (0.36) | MEN1KMT2AESR1 | |
| SCHEMBL5134901 | 0.81 | MEN1 (0.37) | MEN1KMT2AMAOAMAOBGCGR | |
| SCHEMBL5137587 | 0.79 | PDK1 (0.36) | MEN1KMT2AMAOBP2RX7ICMT | |
| SCHEMBL5136213 | 0.77 | C5AR1 (0.50) | — | |
| SCHEMBL5072274 | 0.76 | TSHR (0.35) | MEN1KMT2AESR1 | |
| SCHEMBL4770835 | 0.74 | TSHR (0.39) | MEN1KMT2AESR1ICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |